---
figid: PMC4881529__ijms-17-00707-g003
figtitle: Diversity in GPCR-mediated regulation of Wnt/Beta-catenin
organisms:
- NA
organisms_ner:
- Homo sapiens
pmcid: PMC4881529
filename: ijms-17-00707-g003.jpg
figlink: /pmc/articles/PMC4881529/figure/ijms-17-00707-f003/
number: F3
caption: 'Diversity in GPCR-mediated regulation of Wnt/β-catenin. Wnt stimulation
  of the Fzd/β-catenin pathway activates the phosphoprotein Dvl, leading to inhibition
  of the β-catenin destruction complex composed of APC, the serine/threonine kinase
  glycogen synthase kinase 3β (GSK-3β) and Axin [,]. Cytoplasmic β-catenin then translocates
  to the nucleus, where it cooperates with the Tcf/Lef transcription factors to modify
  transcription of a set of Wnt target genes, primarily cell cycle regulators [].
  EP, a GPCR, utilizes distinct mechanisms to regulate β-catenin expression in cancer.
  EP promotes cancer cell growth by modulating a Gas-Axin-β-catenin signaling axis
  []. Binding of the PGE2 agonist activates Gαs, which binds to Axin displacing APC
  from the destruction complex leading to stabilization and translocation of active
  β-catenin []. The diversity of GPCR signaling allows cancer cells to harness varying
  mechanisms to control key oncogenic targets. ↓: signaling activation; ⊥: signaling
  inhibition; grey curved arrow indicates translocation; dashed line represents nucleus.'
papertitle: G Protein-Coupled Receptor Signaling in Stem Cells and Cancer.
reftext: Jennifer R. Lynch, et al. Int J Mol Sci. 2016 May;17(5):707.
year: '2016'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9625458
figid_alias: PMC4881529__F3
figtype: Figure
redirect_from: /figures/PMC4881529__F3
ndex: a8d45e0b-deb8-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC4881529__ijms-17-00707-g003.html
  '@type': Dataset
  description: 'Diversity in GPCR-mediated regulation of Wnt/β-catenin. Wnt stimulation
    of the Fzd/β-catenin pathway activates the phosphoprotein Dvl, leading to inhibition
    of the β-catenin destruction complex composed of APC, the serine/threonine kinase
    glycogen synthase kinase 3β (GSK-3β) and Axin [,]. Cytoplasmic β-catenin then
    translocates to the nucleus, where it cooperates with the Tcf/Lef transcription
    factors to modify transcription of a set of Wnt target genes, primarily cell cycle
    regulators []. EP, a GPCR, utilizes distinct mechanisms to regulate β-catenin
    expression in cancer. EP promotes cancer cell growth by modulating a Gas-Axin-β-catenin
    signaling axis []. Binding of the PGE2 agonist activates Gαs, which binds to Axin
    displacing APC from the destruction complex leading to stabilization and translocation
    of active β-catenin []. The diversity of GPCR signaling allows cancer cells to
    harness varying mechanisms to control key oncogenic targets. ↓: signaling activation;
    ⊥: signaling inhibition; grey curved arrow indicates translocation; dashed line
    represents nucleus.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - WNT1
  - WNT2
  - WNT2B
  - WNT3
  - WNT3A
  - WNT4
  - WNT6
  - WNT7A
  - WNT7B
  - WNT8A
  - WNT8B
  - WNT9A
  - WNT9B
  - WNT10A
  - WNT10B
  - WNT11
  - WNT16
  - WNT5A
  - WNT5B
  - FZD1
  - FZD10
  - FZD2
  - FZD3
  - FZD4
  - FZD5
  - FZD6
  - FZD7
  - FZD8
  - FZD9
  - MTG1
  - AXIN1
  - AXIN2
  - DVL1
  - DVL1P1
  - DVL2
  - DVL3
  - IFT81
  - CTNNB1
  - APC
  - PROC
  - GSK3B
  - PRKAR1A
  - PRKAR1B
  - PRKAR2A
  - PRKAR2B
  - PRKACA
  - PRKACB
  - PRKACG
  - HNF4A
  - PGE
---
